Literature DB >> 11426981

Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines.

J Rieder1, R Jahnke, M Schloesser, M Seibel, M Czechowski, C Marth, G Hoffmann.   

Abstract

OBJECTIVE: In a recent study, we found different profiles of inducible nitric oxide synthase (iNOS) gene expression in the ovarian carcinoma cell lines OVCAR-3, HOC-7, and 2774 following stimulation by proinflammatory cytokines. The present study was performed to determine whether nitric oxide (NO) synthesis correlates with programmed cell death in these cells.
METHODS: NO-Dependent apoptosis was detected by DNA fragmentation analysis and fluorescence-activated cell sorter analysis.
RESULTS: NO formation in response to interferon gamma (IFN-gamma), interleukin-1beta (IL-1beta), and tumor necrosis factor alpha (TNF-alpha) was correlated with programmed cell death in the investigated cells. DNA fragmentation was most prominent in OVCAR-3 (34.17 +/- 1.81%), less pronounced in HOC-7 (12.86 +/- 0.45%), and undetectable in 2774 (4.54 +/- 0.40%) cells. The rate of apoptosis correlated with the amount of NO formation in cytokine-treated cells. Moreover, coincubation of OVCAR-3 and HOC-7 with the specific iNOS inhibitor aminoguanidine suppressed apoptosis induced by IFN-gamma, IL-1beta, and TNF-alpha.
CONCLUSION: Our data indicate that in OVCAR-3 and HOC-7 cells, NO synthesis induced by IFN-gamma, IL-1beta, and TNF-alpha is correlated with the degree of apoptotic cell death. In clinical situations, this might in part explain the benefit of cytokine application in ovarian carcinoma patients (e.g., documented for IFN-gamma). Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426981     DOI: 10.1006/gyno.2001.6242

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Retrospective chart review of skin cancer presence in the wide excisions.

Authors:  Ye Yuan; Michelle L Duff; Dawn L Sammons; Shiyong Wu
Journal:  World J Clin Cases       Date:  2014-03-16       Impact factor: 1.337

Review 2.  The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Authors:  Katie Lin; Stavroula Baritaki; Silvia Vivarelli; Luca Falzone; Aurora Scalisi; Massimo Libra; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2022-06-17

3.  NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts.

Authors:  Karuppaiyah Selvendiran; Anna Bratasz; Liyue Tong; Louis J Ignarro; Periannan Kuppusamy
Journal:  Cell Cycle       Date:  2007-09-28       Impact factor: 4.534

Review 4.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

5.  NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.

Authors:  Anna Bratasz; Karuppaiyah Selvendiran; Tomasz Wasowicz; Andrey Bobko; Valery V Khramtsov; Louis J Ignarro; Periannan Kuppusamy
Journal:  J Transl Med       Date:  2008-02-26       Impact factor: 5.531

6.  rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition.

Authors:  Bohuslav Melichar; Wei Hu; Rebecca Patenia; Karolina Melicharová; Stacie T Gallardo; Ralph Freedman
Journal:  J Transl Med       Date:  2003-09-19       Impact factor: 5.531

7.  Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.

Authors:  E L Leung; M Fraser; R R Fiscus; B K Tsang
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

8.  Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells.

Authors:  C A Caneba; L Yang; J Baddour; R Curtis; J Win; S Hartig; J Marini; D Nagrath
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.